AIDS prevention campaign spotlights biotech

BioPharm International

Volumn 16, Issue 2, 2003, Pages 20-21

  Wechsler, Jill ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG MANUFACTURE; DRUG RESEARCH; DRUG RESISTANCE; DRUG SAFETY; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; INFECTION PREVENTION; PATENT; SHORT SURVEY; TUBERCULOSIS; UNITED KINGDOM;

EID: 0037313854     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (4)

1. Partnering For Global Health Forum 2002 (Washington, D.C., 3-5 December 2002), www.bio.org/globalhealth.
2. The World Bank Group, the Gates Foundation, and GAVI, Accelerated introduction of priority new vaccines in developing countries (Geneva, Switzerland, September 2002,), www.vaccinealliance. org/site_repository/resources/NewVaccIntros_GAE004OL_2.pdf.
3. The World Health Organization, UNICEF, and The World Bank, State of the World's Vaccines and Immunization, (Geneva, Switzerland, November 2002), www.who.int/mediacentre/events/report.
4. The World Trade Organization, Annex 1C, Agreement on Trade Related Aspects of Intellectual Property Rights, (negotiated at Doha, Qatar, 9-13 November 2001), www.wto.org/english/docs_e/legal_e/ 27-trips.pdf.